3N95
Crystal structure of human CRFR2 alpha extracellular domain in complex with Urocortin 2
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 21-ID-D |
Synchrotron site | APS |
Beamline | 21-ID-D |
Temperature [K] | 100 |
Detector technology | CCD |
Detector | MARMOSAIC 300 mm CCD |
Wavelength(s) | 0.97872 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 54.311, 212.068, 107.319 |
Unit cell angles | 90.00, 104.54, 90.00 |
Refinement procedure
Resolution | 50.000 - 2.720 |
R-factor | 0.226 |
Rwork | 0.224 |
R-free | 0.26600 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3n93 |
RMSD bond length | 0.010 |
RMSD bond angle | 1.229 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | PHASES |
Refinement software | REFMAC (5.5.0109) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.000 | 2.820 |
High resolution limit [Å] | 2.720 | 2.720 |
Rmerge | 0.150 | 0.700 |
Number of reflections | 62181 | |
<I/σ(I)> | 14.28 | 2.82 |
Completeness [%] | 98.9 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 6 | 293 | 12% PEG 6000 0.1M ADA (pH 6.0) 0.1M MgCl2 12% Glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 293K |